Encephalitis (Encephalitis, Rasmussen)

Subscribe to Selected New Research on Encephalitis

2830 relevant articles (148 outcomes, 228 trials/studies) found for this Disease

Description: Inflammation of the BRAIN due to infection, autoimmune processes, toxins, and other conditions. Viral infections (see ENCEPHALITIS, VIRAL) are a relatively frequent cause of this condition.

Also Known As:

Encephalitis, Rasmussen; Brain Inflammation; Encephalitis, Infectious; Infectious Encephalitis; Rasmussen Encephalitis; Rasmussen's Syndrome; Brain Inflammations; Encephalitides, Infectious; Infectious Encephalitides; Inflammation, Brain; Rasmussen Syndrome

Relationship Network

Disease Context: Research Results

Related Diseases

1.	Infection
2.	Acquired Immunodeficiency Syndrome (AIDS)
3.	Measles
4.	Multiple Sclerosis
5.	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia)

Experts

1.	Takahashi, Yukitoshi: 9 articles (03/2008 - 01/2005)
2.	Dalmau, J: 6 articles (09/2008 - 11/2002)
3.	Dou, Huanyu: 6 articles (08/2008 - 10/2003)
4.	Wiley, Clayton A: 6 articles (07/2008 - 03/2002)
5.	Gendelman, Howard E: 6 articles (01/2008 - 10/2003)
6.	Sellner, Johann: 6 articles (12/2006 - 02/2003)
7.	Haas, Jürgen: 5 articles (06/2005 - 01/2002)
8.	Dalmau, Josep: 4 articles (09/2008 - 01/2007)
9.	Scali, C: 4 articles (09/2004 - 06/2001)
10.	Prosperi, C: 4 articles (09/2004 - 06/2001)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Encephalitis:

1.	Acyclovir (Aciclovir)FDA LinkGeneric 11/01/1996 - "With early acyclovir treatment patients with the least severe HSVE were equivalent to those with non-HSV encephalitis with good outcome whereas those with the most severe non-HSV encephalitis were equivalent to those with HSVE with poor outcome." 02/01/1987 - "This report describes a child with herpes simplex virus (HSV) encephalitis who improved dramatically while being treated with acyclovir but subsequently had neurological deterioration and died" 11/01/2008 - "The case report also suggests that acyclovir treatment might be beneficial for the long term outcome in adult EBV encephalitis patients." 09/01/2003 - "Management of herpes simplex virus encephalitis (HSE) has been considerably improved by the development of rapid polymerase chain reaction (PCR) assays and by the use of intravenous acyclovir" 01/01/2006 - "STUDY OBJECTIVE: We evaluate the frequency of empiric acyclovir administration to patients in the emergency department (ED) who are ultimately diagnosed with encephalitis" Order ALL the reference details at left...
2.	AntibodiesIBA 10/01/1997 - "Moreover, passive transfer of antipeptide antibodies conferred significant protection against fatal rodent-adapted MV-induced encephalitis in susceptible mice" 09/15/2007 - "Immunization of young mice with JE-X/5'CprME(S) virus elicited neutralizing antibodies against JE Nakayama virus and conferred protection against encephalitis following challenge with JE Nakayama virus" 01/01/2007 - "RESULTS/CONCLUSIONS: Here, we show that long-term systemic administration of anti-APP beta-site antibodies to Tg2576 transgenic mice improved mouse cognitive functions associated with a reduction in both brain inflammation and the incidence of microhemorrhage" 03/01/2006 - "Neutralizing anti-WNV antibodies have been shown to be crucial for protection against WNV encephalitis" 05/25/2003 - "Passive transfer of anti-wtCPMV antibodies into BALB/c mice conferred partial protection against measles virus induced encephalitis" Order ALL the reference details at left...
3.	Pyrimethamine (Daraprim)FDA Link 03/01/1994 - "Pyrimethamine as primary prophylaxis of toxoplasmic encephalitis in patients infected with human immunodeficiency virus: open study." 02/01/1994 - "Primary prophylaxis with pyrimethamine for toxoplasmic encephalitis in patients with advanced human immunodeficiency virus disease: results of a randomized trial" 04/01/1998 - "Increased mortality has been observed when HIV-infected patients were treated with pyrimethamine (Pyr) as prophylaxis for toxoplasmic encephalitis, suggesting that Pyr might possess immunosuppressive activity" 10/01/1995 - "Relapse of Toxoplasma encephalitis and susceptibility to pyrimethamine: lack of evidence of treatment-induced resistance." 03/01/1997 - "In a randomized, double-blind, placebo-controlled study of pyrimethamine as primary prophylaxis for toxoplasmic encephalitis, the incidence of rash (per hundred patient-years) was 8.1 in the pyrimethamine group versus 1.5 in the placebo group (P < .0002)" Order ALL the reference details at left...
4.	AntigensIBA 02/28/1996 - "Previously, examination by brain biopsy was regarded as the gold standard for detecting the presence of virus or virus antigen in suspected cases of encephalitis caused by herpes simplex virus, but the extraction of the sample material requires experience, and is not without risk" 01/01/2006 - "The present study is an attempt to standardize and evaluate the usefulness of SVC for the laboratory diagnosis of JE, WN and Den-2 encephalitis cases and to compare it with Indirect Immunofluorescence (IIF) technique that detects cell associated virus antigen" 01/01/2008 - "Autoimmune encephalitis is a heterogeneous group of disorders probably resulting from a reaction of the immune system against antigens of the central nervous system" 07/01/2007 - "Antigen-specific cytotoxic T lymphocytes protect against lethal West Nile virus encephalitis." 02/01/2006 - "Post-mortem examination of the brain revealed viral-type non-suppurative encephalitis, and influenza virus antigen was demonstrated by immunolabelling of sections of nasal mucosa" Order ALL the reference details at left...
5.	Monoclonal AntibodiesIBA 01/01/1995 - "Monoclonal antibodies (MAbs) prepared against the yellow fever virus (YF) vaccine strain 17D (17D YF) envelope E protein were used to investigate Fc piece involvement in antibody-mediated protection against YF encephalitis in mice 17D YF passaged either in Vero cells or in mouse brain (P-YF) to increase neurovirulence was used" 02/01/1995 - "In this study, infusions of anti-MHV neutralizing monoclonal antibodies were administered to protect mice from the MHV-JHM-induced acute encephalitis and to allow survival until virus spread to the spinal cord" 11/25/2008 - "Five dogs and four cats from Germany suffering from encephalitis revealed positive immunoreactivity using two West Nile virus (WNV) specific monoclonal antibodies in brain and in kidney" 02/01/1992 - "Mapping neuroinvasiveness of the herpes simplex virus type 1 encephalitis-inducing strain 2762 by the use of monoclonal antibodies." 09/01/1990 - "These monoclonal antibodies were used to identify Acanthamoeba trophozoites in infected brain sections of a patient who died of suspected Acanthamoeba-caused granulomatous amoebic encephalitis, demonstrating potential utility in the direct identification of N" Order ALL the reference details at left...
6.	VaccinesIBA 03/01/2000 - "Only recombinant SFV particles administered twice gave full protection against neuronal degeneration and encephalitis induced by two of the three challenge strains, and partial protection against the highly virulent strain, whereas the other vaccines tested gave lower levels of partial protection." 03/01/1999 - "This study suggests that the NYVAC-JEV and ALVAC-JEV vaccines are safe and immunogenic in monkeys and that the NYVAC-JEV and BIKEN vaccines are effective in protecting monkeys from encephalitis." 03/01/1999 - "This study demonstrates that the virus strain, route of inoculation, dose, and the outcome measure (encephalitis) are suitable for assessment of protective efficacy of candidate JE vaccines." 03/01/1981 - "In this study we have characterized the specific antibody responses in mice vaccinated with the three SFV vaccines and correlated them with the protection against SFV encephalitis" 11/01/2007 - "Comparative efficacies of three commercially available vaccines against West Nile Virus (WNV) in a short-duration challenge trial involving an equine WNV encephalitis model." Order ALL the reference details at left...
7.	Sulfadiazine (Sulphadiazine)FDA Link 04/01/1990 - "Most mice (6 of 10) treated for 3 days with 1 mg/ml sulfadiazine in drinking water developed encephalitis after drug treatment was stopped" 08/01/2005 - "Renal failure caused by sulfadiazine in a HIV patient with toxoplasmic encephalitis]" 11/01/2000 - "Kidney failure caused by sulphadiazine in patients with toxoplasma encephalitis]" 11/19/1994 - "In the last few years high dose sulfadiazine therapy has been widely used for treatment of toxoplasmic encephalitis in AIDS patients" 05/01/1991 - "We present here four patients with AIDS treated for toxoplasmic encephalitis who developed sulfadiazine-induced crystalluria" Order ALL the reference details at left...
8.	Vidarabine (Vira-A)FDA Link 02/01/1985 - "Ara-A provided protection against HSV-1 encephalitis in immunosuppressed mice inoculated with a low dose (200 PFU/mouse) of MMUdRR virus or wild-type HSV-1" 07/01/1981 - "In this last article of a four-part series, the authors review clinical studies that have to date led to the licensing of ara-A for HSV encephalitis but have not yet clearly defined its role in the immunosuppressed or in neonates." 12/01/1980 - "This study addresses the issues of brain biopsy and adenine arabinoside (Ara-A) therapy in the clinical management of patients suspected of having herpes simplex virus encephalitis (HVE)" 02/01/1998 - "Herpetic brainstem encephalitis was diagnosed, and he received 900 mg/day vidarabine" 02/01/1990 - "In our view ara-A treatment should be taken in consideration in case of acute encephalitis unresponsive to Acv." Order ALL the reference details at left...
9.	Ganciclovir (Cytovene)FDA LinkGeneric 03/30/2007 - "Intravenous ganciclovir consistently induces remission of persistent Epstein-Barr encephalitis in an HIV-1-infected patient." 11/01/1994 - "Nevertheless, the management of CMV-related encephalitis appears to be problematic and data in the literature on the clinical efficacy of ganciclovir therapy is sparse and controversial" 07/01/2008 - "The present case indicates that prolonged disturbance of consciousness due to cytomegalovirus encephalitis could be restored with continuous ganciclovir administration." 12/01/2006 - "Human herpes virus-6 encephalitis in a paediatric bone marrow recipient: successful treatment with pharmacokinetic monitoring and high doses of ganciclovir." 07/01/1999 - "Etiotropic treatment is to be prescribed in CMV encephalitis with gancyclovir (cymeven Roche) in the earliest periods of the course of the disease." Order ALL the reference details at left...
10.	Clindamycin (Cleocin)FDA LinkGeneric 04/01/1987 - "We investigated the efficacy of clindamycin in a murine model of toxoplasmic encephalitis using direct intracerebral inoculation" 03/01/1991 - "The interim results are presented of an ongoing large-scale, prospective, randomized study to determine the potential role of clindamycin in the treatment of toxoplasmic encephalitis" 01/01/1994 - "Intravenous clindamycin as monodrug in treatment of 2 patients with toxoplasmic encephalitis]" 11/01/1988 - "Treatment of toxoplasmic encephalitis with intravenous clindamycin." 04/01/1987 - "These observations suggest that clindamycin may have a role in the therapy of toxoplasmic encephalitis." Order ALL the reference details at left...

Therapies and Procedures

1.	Immunotherapy 08/01/2003 - "Approved immunotherapies are only moderately effective in reducing disease exacerbations and brain inflammation in a subset of patients" 04/01/2005 - "